McKesson Corporation $MCK Shares Bought by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC lifted its position in shares of McKesson Corporation (NYSE:MCK) by 7.3% during the third quarter, Holdings Channel reports. The firm owned 49,169 shares of the company’s stock after acquiring an additional 3,363 shares during the quarter. Commonwealth Equity Services LLC’s holdings in McKesson were worth $41,981,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in MCK. BlackRock Inc. purchased a new position in McKesson during the 2nd quarter worth approximately $8,156,743,000. Bank of America Corp DE purchased a new stake in McKesson in the second quarter valued at approximately $998,896,000. Legal & General Group Plc purchased a new stake in McKesson in the second quarter valued at approximately $656,566,000. The Manufacturers Life Insurance Company acquired a new stake in shares of McKesson in the second quarter valued at approximately $651,462,000. Finally, Bank of New York Mellon Corp acquired a new stake in shares of McKesson in the second quarter valued at approximately $599,060,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Bradley Lerman sold 301 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $892.33, for a total value of $268,591.33. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Francisco Fraga sold 650 shares of the firm’s stock in a transaction that occurred on Thursday, November 5th. The stock was sold at an average price of $1,102.96, for a total transaction of $716,924.00. Following the transaction, the executive vice president directly owned 4,414 shares of the company’s stock, valued at approximately $4,868,465.44. This trade represents a 12.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,462 shares of company stock worth $2,511,106 over the last ninety days. 0.06% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Bank of America raised their target price on shares of McKesson from $950.00 to $1,050.00 in a research report on Thursday, August 6th. Wells Fargo & Company raised their price objective on shares of McKesson from $812.00 to $933.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 11th. Argus raised their price target on McKesson from $850.00 to $970.00 and gave the stock a “buy” rating in a report on Thursday, September 3rd. Mizuho boosted their price objective on shares of McKesson from $905.00 to $1,020.00 and gave the company a “neutral” rating in a research note on Tuesday, October 20th. Finally, Barclays increased their target price on McKesson from $925.00 to $1,000.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 19th. Fifteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, McKesson has an average rating of “Moderate Buy” and an average price target of $1,026.18.

Key McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson beat fiscal Q2 2027 estimates, reporting adjusted EPS of $11.68 and revenue of about $111 billion, up roughly 7.5% year over year. The company also raised its fiscal 2027 adjusted EPS outlook to $45.60–$46.40, supported by specialty-drug demand, higher prescription volumes and operating gains. MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised
• Positive Sentiment: Analyst sentiment has strengthened: UBS raised its price target to $1,250 and maintained a Buy rating, while TD Cowen and Leerink Partners lifted targets to $1,200. Separately, Zacks upgraded MCK to Rank #2 (Buy), citing improving earnings prospects. Zacks upgrades McKesson to Buy
• Neutral Sentiment: EVP Francisco Fraga sold 650 shares under a pre-arranged Rule 10b5-1 plan and retained 4,414 shares. The filing does not explain the purpose of this latest sale; an earlier sale was described as covering tax withholding on vested equity awards. SEC filing
• Negative Sentiment: RBC raised its price target but kept a Sector Perform rating and set a $965 target, below the recent share price. That more cautious view may temper enthusiasm after MCK’s strong run. RBC comments on McKesson’s execution

McKesson Stock Down 1.0%

NYSE:MCK opened at $1,060.79 on Friday. McKesson Corporation has a 52-week low of $723.68 and a 52-week high of $1,121.50. The stock has a fifty day simple moving average of $938.13 and a 200-day simple moving average of $868.12. The company has a market capitalization of $122.48 billion, a PE ratio of 27.28, a price-to-earnings-growth ratio of 2.08 and a beta of 0.27.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $11.68 EPS for the quarter, beating analysts’ consensus estimates of $10.72 by $0.96. McKesson had a net margin of 1.12% and a negative return on equity of 202.94%. The firm had revenue of $110.96 billion for the quarter, compared to analysts’ expectations of $109.90 billion. During the same period in the prior year, the company earned $9.86 EPS. The firm’s revenue was up 7.5% on a year-over-year basis. As a group, equities analysts anticipate that McKesson Corporation will post 46.21 earnings per share for the current year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Tuesday, December 1st will be issued a $0.94 dividend. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Tuesday, December 1st. McKesson’s dividend payout ratio is 9.67%.

About McKesson

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers.

The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care.

Founded in 1833, McKesson serves customers primarily in the United States and Canada.